Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Louise Claire Young
Introduction
Louise Claire Young, an accomplished inventor based in Strathclyde, GB, has made significant contributions to the field of pharmaceuticals through her innovative research. With a singular patent to her name, her work has the potential to influence various medical applications.
Latest Patents
Louise Claire Young's patent, titled "Par-2-activating peptide derivative and pharmaceutical composition using the same," relates to a unique peptide derivative represented by a specific general formula. This invention encompasses a pharmaceutical composition that includes this peptide derivative or a salt thereof, combined with a pharmaceutically acceptable carrier. The peptide derivative is designed to serve as a prophylactic and therapeutic agent for various conditions, ranging from dysfunction of masticatory, dysphagia, and dysgeusia, to more serious ailments like stomach ulcers, keratitis, and Sjogren's syndrome.
Career Highlights
Throughout her career, Louise has had the privilege of working with prominent institutions such as the University of Edinburgh and the University of Strathclyde. Her contributions in these esteemed institutions have further bolstered her reputation as a pioneering inventor and researcher in the field of pharmaceuticals.
Collaborations
Louise has collaborated with renowned coworkers, including Robert Ramage and Robin Plevin. Their joint efforts exemplify the collaborative spirit that drives innovation in research and development, enhancing the breadth and impact of their scientific inquiries.
Conclusion
In summary, Louise Claire Young stands as a notable figure in the realm of pharmaceutical inventions. Her groundbreaking work not only highlights her ingenuity but also paves the way for advancements in medical treatments that could significantly enhance patient care and outcomes. The field of innovation continues to benefit from her contributions, making her an inspiring figure among inventors today.